Oct 7th , 24th and 26th 2019 – Outreach on Hepatitis B & C at Igbaraoke in Ifedore LGA.
Awareness and free Hepatitis B & C Screening done at the following centres
7th October
1. Molete Area
Total No Screened: 7
Non Reactive : 5
Reactive : 2 (M:1, F:1)
2. 24TH October – Opening Space Opposite Anglican Church
Total No screened : 39, M:14, F:25
Non – reactive : 34
Reactive :5 (M:4, F:1)
B. Oba’s Market, Ilara mokin
Total Screened: 13
Non reactive :13 (all females)
3. 26th October – Faith Model Secondary School, Igbaraoke
Total No Screened : 145 (students 134; staff:11)
Non Reactive : 137
HBV Reactive: Students 5(F :4, M: L)
HCV Reactive Students 2: Female.
23rd – 28th July 2022
Health Talk and free Screening in Schools and communities
Day 1 – Sensitization and free screening at Olokuta Community Idanre LGA
No Screened :33
Reactive : 3
Non Reactive : 30
Day 2: NASFAT Congregation, Oba ile
No Screened : 155
Non reactive : 144
Reactive : 9
Day 2: Ireakari Community
Total Screened : 89
Non Reactive : 86
Reactive : 3
Day 3: Main Minaret College, Obaile, Akure
Total Student: 65
No of Staff Screened : 8
Non Reactive : 8
Day 3: Complex
No screened : 28
Non reactive : 28
Day 4 Akure Muslim College
No of students : 150
No of teachers : 10
Day 5 Oladimeji’s College
Total No of Students : 91
No of Staff ; 9
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close